Spectrum Management Group, LLC Gilead Sciences, Inc. Transaction History

Spectrum Management Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $9,556 - $11,975	-165 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $11,168 - $12,049	165 New	165 $12,000
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $15,529 - $17,414	-251 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$62.53 - $70.05 $15,695 - $17,582	251 New	251 $16,000
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $14,568 - $17,760	-200 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $1,494 - $1,753	-21 Reduced 9.5%	200 $14,000
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $15,936 - $18,888	221	221 $18,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Spectrum Management Group, LLC with notifications on news.